How the brain keeps blood sugar levels in check

Car­di­nal Health’s dis­tri­b­u­tion con­tract with phar­ma­cy ben­e­fit man­ag­er Op­tum­Rx will ex­pire at the end of June and it will not be re­newed, the com­pa­ny said.

The FDA is as­sem­bling a new ad­vi­so­ry com­mit­tee to eval­u­ate po­ten­tial treat­ments for ge­net­ic meta­bol­ic dis­eases, the agency an­nounced Tues­day. Ge­net­ic meta­bol­ic dis­eases are typ­i­cal­ly